Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide modulation of inflammatory processes within the brain

J M Lipton1, A Catania, R Delgado

  • 1University of Texas Southwestern Medical Center at Dallas, Dallas, Tex., USA. james.lipton@email.swmed.edu

Neuroimmunomodulation
|September 8, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study.

The Journal of antimicrobial chemotherapy·2025
Same author

Exploring perceptions of factors aiding the development of critical thinking in adult dysphagia: A study among fourth-year speech-language pathology students.

The clinical teacher·2023
Same author

R106C TFG variant causes infantile neuroaxonal dystrophy "plus" syndrome.

Neurogenetics·2018
Same author

Selective inhibitors of aurora kinases inhibit proliferation, reduce cell viability and impair cell cycle progression in papillary thyroid carcinoma cells.

Journal of biological regulators and homeostatic agents·2016
Same author

PAPILLARY THYROID CANCER IS CHARACTERIZED BY ALTERED EXPRESSION OF GENES INVOLVED IN THE SUMOYLATION PROCESS.

Journal of biological regulators and homeostatic agents·2015
Same author

Metachronous elastofibromas.

La Clinica terapeutica·2014

Alpha-melanocyte-stimulating hormone (alpha-MSH) reduces brain inflammation by inhibiting pro-inflammatory agents like tumor necrosis factor-alpha (TNF-alpha). This peptide shows potential for treating CNS disorders by modulating neuroinflammation.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Inflammatory processes are implicated in various central nervous system (CNS) disorders, including neurodegenerative diseases and stroke.
  • Elevated levels of cytokines, particularly tumor necrosis factor-alpha (TNF-alpha), characterize CNS inflammation.
  • Controlling CNS inflammation is crucial for preserving neural function.

Purpose of the Study:

  • To investigate the role of alpha-melanocyte-stimulating hormone (alpha-MSH) in modulating central nervous system (CNS) inflammation.
  • To determine if alpha-MSH acts directly within the brain to reduce inflammation.
  • To explore the potential of alpha-MSH as a therapeutic agent for CNS inflammatory conditions.

Main Methods:

  • Murine microglia and human astrocytes were used to assess the effects of alpha-MSH on the production of TNF-alpha and nitric oxide.

Related Experiment Videos

  • In vitro studies tested the impact of alpha-MSH (1-13) and alpha-MSH (11-13) on TNF-alpha production in astrocytes.
  • A canine model of ischemia/reperfusion in the posterior circulation was employed to evaluate the efficacy of systemic alpha-MSH administration on functional deficits and inflammatory responses.

    • Main Results:

    • Alpha-MSH significantly reduced the production of TNF-alpha and nitric oxide by murine microglia.
    • Both alpha-MSH (1-13) and alpha-MSH (11-13) demonstrated an ability to decrease TNF-alpha production in human astrocytes.
    • Systemic administration of alpha-MSH during ischemia/reperfusion in dogs mitigated functional deficits, evidenced by improved auditory-evoked potentials, with greater effect when given during both phases.

    Conclusions:

    • Alpha-melanocyte-stimulating hormone (alpha-MSH) directly modulates inflammatory responses within the brain, similar to its peripheral effects.
    • Alpha-MSH exhibits anti-inflammatory properties by inhibiting key pro-inflammatory mediators like TNF-alpha and nitric oxide.
    • These findings suggest that alpha-MSH holds therapeutic potential for managing CNS inflammation and related disorders.